
Overview
BART produces food ingredients, liposomal ingredients, and nutrients for the pharmaceutical and nutraceutical industries. It also supplies ingredients for personal care products and develops formulations through its research and development department.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $178,053 | |
| Profit allocation | Dividend and reserves | |
| Loans and borrowings | $5,166,977 | |
| Capital expenditure | $6,242,516 | |
| Planned capital expenditure (next year) | $18,206,931 | |
| Foreign sales | 26.97% of revenue ($11,192,082) |
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 76 days late). All were audited by a statutory auditor.
- 202529/05/2026
- 202416/06/2025
- 202314/06/2024
- 202215/07/2023
- 202129/09/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

BART at Fi Europe 2026 – Discover Our Technologies for the Food Industry

Meet BART at Fi Europe 2026 – Explore Our Ingredient Technologies
BART will be exhibiting at Fi Europe 2026, taking place in Frankfurt from 17–19 November. Join us at stand 31B74 to discover our ingredient technologies and explore how they can support your next food and beverage innovation. From technology to real-world applications For 30 years, BART has been developing solutions for the food industry, combining […]

Meet BART at SupplySide Global 2026: Innovation, Performance & Liposomal Technology
We’re heading to Las Vegas! BART is excited to announce its participation in SupplySide Global 2026, one of the leading international events for the dietary supplement, food, and beverage industries. Visit us at Booth 3437 to explore innovative ingredient solutions, discover new formulation possibilities, and connect with our team. Discover Liposovit®: One Technology. Multiple Possibilities. […]

Let's Meet at SupplySide Global 2026 in Las Vegas!

HPCI Warsaw 2026 – Thank You for the Inspiring Meetings!
This year’s edition of HPCI Warsaw was an exceptionally busy and successful event for BART. Two days at Expo XXI Warsaw were filled with inspiring meetings, new connections and valuable conversations with professionals from the cosmetics and detergents industries. We would like to thank everyone who visited us at Booth 341. The strong interest in […]

HPCI Warsaw 2026 – thank you for the inspiring meetings!
Industry
Offer
- Liposomal ingredients
- Vitamins
- Minerals
- Dyes
- Flavourings
- Superfoods
Websites
- bart.plBart – innowacyjne rozwiązania liposomalne i wysokiej jakości składniki dla przemysłu spożywczego, farmaceutycznego i kosmetycznegoWordPress 7.1LinkedIn AdsGoogle Tag ManagerNginx
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2020.
| Mark | Protected until | |
|---|---|---|
| Liposovit | Oct 21, 2030 |
Job offers
The company has its own careers page: bart.pl/dolacz-do-nas.
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Pietruszyński age 54 | 465 | $6,280.39 | 46.0396% |
| 465 | $6,280.39 | 46.0396% | |
Others | 80 | $1,080.50 | 7.9208% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1996-11-26.
24 1140 1010 0000 4870 9200 1016
81 1090 1014 0000 0001 6681 5292
58 1090 1014 0000 0001 5137 7962
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $1.4M$1,421,303 |
Buildings and premises | $1.5M$1,496,349 |
Investment property | $2.2M$2,204,961 |
Public aid
56 public aid cases recorded, with a total value of $9,452,151.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 23, 2026 | Aid for SME participation in trade fairs | $264.6K$264,550 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Jul 23, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $971$971 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Nov 20, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $113.9K$113,868 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-02-01 | Development of innovative stabilization methods and new formulations of natural dyes and coloring foods for the food industry | $243K$242,988 | Regional Operational Programme for the Mazowieckie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Stada Pharm sp. z o.o. | $98,071,375.86 | walmark.eu | ||
| Oleofarm sp. z o.o. | $68,110,367.86 | oleofarm.pl | ||
| Unipro sp. z o.o. | $62,412,723.24 | activlab.pl | ||
| Ostrovit sp. z o.o. | $47,409,120.93 | ostrovit.com | ||
| Medicaline sp. z o.o. | $46,877,712.69 | medicaline.pl | ||
| Trec Nutrition sp. z o.o. | $36,555,310.92 | trecnutrition.com | ||
| Natubay sp. z o.o. | $34,559,262.94 | natubay.pl | ||
| Ekamedica sp. z o.o. + limited partnership | $18,889,143.89 | ekamedica.pl | ||
| Nutropharma sp. z o.o. | $13,240,122.91 | nutropharma.pl | ||
| Aura Herbals sp. z o.o. | $11,101,586.81 | auraherbals.pl |
FAQ
Last updated: 2026-05-29